Physician
Hematology
Dr. Mohamad A. Hussein, MD
|
|
Give Review
Mohamad A. Hussein works in the field of Hematology. He received awards:"CMS Meaningful Use Stage 1 Certification". Mohamad Hussein is a published doctor and has 37 publications published. The lastest was: 'Patterns of total cost and economic consequences of progression for patients with newly diagnosed multiple myeloma.'
Publications
- Cytogenetic prioritization with inclusion of molecular markers predicts outcome in previously untreated patients with chronic lymphocytic leukemia treated with fludara...
- Patterns of total cost and economic consequences of progression for patients with newly diagnosed multiple Myeloma.
- Quantification of peptides from immunoglobulin constant and variable regions by LC-MRM MS for assessment of multiple Myeloma patients.
- A phase II trial of BAY 43-9006 (sorafenib) (NSC-724772) in patients with relapsing and resistant multiple Myeloma: SWOG S0434.
- Mature results of MM-011: A phase I/II trial of liposomal doxorubicin, Vincristine, Dexamethasone, and Lenalidomide combination therapy followed by lenalidomide mainte...
- Phase II study of pegylated liposomal doxorubicin, low-dose dexamethasone, and lenalidomide in patients with newly diagnosed multiple Myeloma.
- Total cost comparison in relapsed/refractory multiple Myeloma.
- Incidence of Therapy-related Myeloid Neoplasia after Initial Therapy for CLL with Fludarabine-Cyclophosphamide versus Fludarabine: Long-Term Follow-up of US Intergroup...
- Lenalidomide and high-dose dexamethasone compared with dexamethasone as initial therapy for multiple Myeloma: a randomized Southwest Oncology Group trial (S0232).
- Prediction of response and progression in multiple Myeloma with serum free light chains assay: corroboration of the serum free light chain response definitions.
- Phase II study of thalidomide plus dexamethasone induction followed by tandem melphalan-based autotransplantation and thalidomide-plus-prednisone maintenance for untre...
- G1P3, an IFN-induced survival factor, antagonizes TRAIL-induced apoptosis in human Myeloma cells.
- CD28-mediated regulation of multiple Myeloma cell proliferation and survival.
- Preclinical rationale, mechanisms of action, and clinical activity of anthracyclines in Myeloma.
- Phase III trial of fludarabine plus cyclophosphamide compared with fludarabine for patients with previously untreated chronic lymphocytic leukemia: US Intergroup Trial...
- Multiple Myeloma: most common end-organ damage and management.
- Thrombotic complications in patients with newly diagnosed multiple Myeloma treated with lenalidomide and dexamethasone: benefit of aspirin prophylaxis.
- Phase 2 study of pegylated liposomal doxorubicin, vincristine, decreased-frequency dexamethasone, and thalidomide in newly diagnosed and relapsed-refractory multiple m...
- Pegylated liposomal doxorubicin, vincristine, and dexamethasone provide significant reduction in toxicity compared with doxorubicin, vincristine, and dexamethasone in ...
- Immunomodulatory analogues of thalidomide in the treatment of multiple Myeloma.
- The role of aspirin in the prevention of thrombotic complications of thalidomide and anthracycline-based chemotherapy for multiple Myeloma.
- Advances in multiple Myeloma and spine disease.
- Lenalidomide: patient management strategies.
- Role of liposomal anthracyclines in the treatment of multiple Myeloma.
- Apoptosis of multiple Myeloma.
- New treatment strategies for multiple Myeloma.
- Prevalence of vitamin B12 deficiency in patients with plasma cell dyscrasias: a retrospective review.
- Monoclonal gammopathy of undetermined significance and multiple Myeloma are associated with an increased incidence of venothromboembolic disease.
- Long-term efficacy and safety of zoledronic acid compared with pamidronate disodium in the treatment of skeletal complications in patients with advanced multiple myelo...
- Trials of arsenic trioxide in multiple Myeloma.
- A Phase I-II trial of polyethylene glycol-conjugated L-asparaginase in patients with multiple Myeloma.
- Modifications to therapy for multiple Myeloma: pegylated liposomal Doxorubicin in combination with vincristine, reduced-dose dexamethasone, and thalidomide.
- A Phase II trial of pegylated liposomal doxorubicin, vincristine, and reduced-dose dexamethasone combination therapy in newly diagnosed multiple Myeloma patients.
- Multiple Myeloma: present and future.
- Nontraditional cytotoxic therapies for relapsed/refractory multiple Myeloma.
- Use of melphalan, thalidomide, and dexamethasone in treatment of refractory and relapsed multiple Myeloma.
Schools
Ain Shams University Faculty Of Medicine
Ein Shams University Hosps
Cleveland Clinic Foundation
University Miss Med Center
University MD Canc Center
Conditions Treated
- Anemia
- Liver Cancer
- Myeloma
- Pancreatic Cancer
Doctors Specialties
- Medical Oncology
- Oncology
- Hematology
Accepted Insurances
- Aetna HMO
- Choice Plus POS II
- Blue Card PPO
- Blue Care HMO
- Blue Select
- BlueDental Choice
- NetworkBlue
- Cigna HMO
- Cigna PPO
- Great West Healthcare-Cigna PPO
- LocalPlus
- Open Access Plus
- Wellpath Preferred PPO
- Employer Group Open Access HMO
- Employer Group PPO
- First Health (Coventry Health Care) PPO
- Choice Care PPO
- Preferred PPO
- Select HMO
- Tampa Bay CoreNet
- Tampa Bay HUMx HMOx
- MultiPlan PPO
- PHCS Network PPO
- Choice Plus POS
- Navigate HMO
- Navigate POS
- Neighborhood Health Partnership
- Options PPO
Awards
- CMS Meaningful Use Stage 1 Certification
Education
-
University of Maryland -
Cleveland Clinic Foundation -
University of Mississippi Medical Center -
Ain Shams University Faculty of Medicine
Hospital
-
Memorial Hospital of Tampa -
Tampa General Hospital
Helpful Reviews
Similar Doctors
|
|
Dr. Lewis E. Auerbach, MD
 This Doctor is OpenDoctor Recommended.
|
|
Dr. Bijal D. Shah, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Rachid C. Baz, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Mark S. Robbins, MD |
|
|
Dr. Benjamin Djulbegovic, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Dr. Bruce O. Hough, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Jeffrey Lancet, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Dr. Julio C. Chavez, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Eric Padron, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Gerold Bepler, MD |